HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yiling Lu Selected Research

Yiling Lu Research Topics

Disease

113Neoplasms (Cancer)
05/2022 - 02/2002
29Breast Neoplasms (Breast Cancer)
05/2022 - 04/2003
28Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 01/2002
14Melanoma (Melanoma, Malignant)
01/2022 - 01/2016
9Carcinogenesis
12/2017 - 10/2003
7Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 07/2011
7Carcinoma (Carcinomatosis)
10/2017 - 02/2002
6Glioma (Gliomas)
01/2022 - 04/2002
5Neoplasm Metastasis (Metastasis)
01/2020 - 06/2009
4Lung Neoplasms (Lung Cancer)
01/2016 - 06/2003
4Ascites
01/2009 - 02/2002
3Head and Neck Neoplasms (Head and Neck Cancer)
05/2014 - 07/2013
2Pathologic Complete Response
05/2022 - 01/2022
2Disease Progression
11/2020 - 01/2015
2Starvation
02/2018 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
12/2017 - 11/2017
2Ovarian Epithelial Carcinoma
10/2017 - 01/2009
2Hypoxia (Hypoxemia)
01/2017 - 03/2016
2Prostatic Neoplasms (Prostate Cancer)
11/2016 - 12/2007
2Renal Cell Carcinoma (Grawitz Tumor)
03/2016 - 01/2016
2Glioblastoma (Glioblastoma Multiforme)
06/2010 - 11/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2006 - 04/2006
2Leukemia
10/2006 - 04/2006
1Residual Neoplasm
05/2022
1Bites and Stings (Sting)
01/2022
1Sarcoma (Soft Tissue Sarcoma)
11/2020
1COVID-19
01/2020

Drug/Important Bio-Agent (IBA)

60Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2003
18Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2009
15Pharmaceutical PreparationsIBA
12/2020 - 12/2005
13MicroRNAs (MicroRNA)IBA
01/2022 - 07/2013
11Biological ProductsIBA
10/2021 - 11/2012
11Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020 - 04/2003
9Messenger RNA (mRNA)IBA
01/2021 - 04/2003
8Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2021 - 06/2003
8Phosphotransferases (Kinase)IBA
12/2020 - 06/2003
8Small Interfering RNA (siRNA)IBA
11/2020 - 06/2009
7ProteomeIBA
01/2019 - 12/2010
6AntibodiesIBA
01/2020 - 01/2005
6Estrogen ReceptorsIBA
12/2019 - 06/2009
6Phosphatidylinositols (Phosphatidylinositol)IBA
12/2015 - 02/2002
5Long Noncoding RNAIBA
01/2022 - 09/2014
5DNA (Deoxyribonucleic Acid)IBA
11/2021 - 06/2015
5lysophosphatidic acidIBA
04/2017 - 03/2004
5Lysophosphatidic Acid ReceptorsIBA
06/2009 - 01/2002
4Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2022 - 01/2017
4RNA (Ribonucleic Acid)IBA
11/2020 - 06/2015
4EnzymesIBA
01/2020 - 08/2004
4immune RNA (I-RNA)IBA
12/2019 - 10/2015
4CytokinesIBA
01/2018 - 03/2004
4PhosphoproteinsIBA
01/2017 - 07/2009
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017 - 04/2003
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2016 - 04/2002
3Cisplatin (Platino)FDA LinkGeneric
10/2022 - 12/2014
3talazoparibIBA
05/2022 - 05/2019
3Mechanistic Target of Rapamycin Complex 1IBA
01/2021 - 11/2017
3NucleotidesIBA
12/2019 - 01/2018
3Protein Isoforms (Isoforms)IBA
07/2018 - 06/2003
3Adenosine (Adenocard)FDA LinkGeneric
01/2018 - 10/2015
3InosineFDA Link
01/2018 - 10/2015
3Drug CombinationsIBA
01/2018 - 09/2010
3Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 02/2002
3Estrogens (Estrogen)FDA Link
02/2016 - 11/2012
3TOR Serine-Threonine KinasesIBA
12/2008 - 04/2003
2Immune Checkpoint InhibitorsIBA
01/2022 - 11/2017
2Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 12/2021
2InterferonsIBA
01/2022 - 10/2003
2alpha-2'-deoxythioguanosineIBA
12/2021 - 10/2018
2NucleosidesIBA
12/2021 - 10/2018
2Sirolimus (Rapamycin)FDA Link
01/2021 - 01/2012
2Lapatinib (GW572016)FDA Link
12/2020 - 01/2015
2IntegrinsIBA
12/2020 - 01/2008
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 12/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 03/2006
2Hormones (Hormone)IBA
11/2019 - 04/2003
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2019 - 01/2017
2Insulin-Like PeptidesIBA
01/2018 - 09/2010
2corilaginIBA
10/2017 - 02/2013
2Estrogen Receptor Modulators (Antiestrogen)IBA
02/2016 - 11/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2014 - 10/2003
2Tyrosine (L-Tyrosine)FDA Link
10/2014 - 10/2003
2Fulvestrant (Faslodex)FDA Link
10/2014 - 11/2012
2Antineoplastic Agents (Antineoplastics)IBA
11/2012 - 06/2009
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2012 - 12/2008
2Transcription Factors (Transcription Factor)IBA
01/2012 - 03/2004
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
07/2011 - 04/2009
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2008 - 02/2002
2Trastuzumab (Herceptin)FDA Link
01/2005 - 10/2003
2LysophospholipidsIBA
08/2004 - 01/2002
2Indicators and Reagents (Reagents)IBA
10/2003 - 04/2003
2LipidsIBA
06/2003 - 04/2002
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2022
1Gentian Violet (Violet, Crystal)FDA Link
01/2022
1dactolisibIBA
01/2021
1Thiostrepton (Gargon)IBA
12/2020
1Collagenases (Collagenase)FDA Link
11/2020
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2020

Therapy/Procedure

49Therapeutics
10/2022 - 01/2002
7Drug Therapy (Chemotherapy)
11/2017 - 02/2002
2Immunotherapy
01/2018 - 01/2018